Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,669 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background.
Tomati V, Costa S, Capurro V, Pesce E, Pastorino C, Lena M, Sondo E, Di Duca M, Cresta F, Cristadoro S, Zara F, Galietta LJV, Bocciardi R, Castellani C, Lucanto MC, Pedemonte N. Tomati V, et al. Among authors: costa s. J Cyst Fibros. 2023 May;22(3):525-537. doi: 10.1016/j.jcf.2022.12.005. Epub 2022 Dec 19. J Cyst Fibros. 2023. PMID: 36543707
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study.
Daines CL, Tullis E, Costa S, Linnemann RW, Mall MA, McKone EF, Polineni D, Quon BS, Ringshausen FC, Rowe SM, Selvadurai H, Taylor-Cousar JL, Withers NJ, Ahluwalia N, Moskowitz SM, Prieto-Centurion V, Tan YV, Tian S, Weinstock T, Xuan F, Zhang Y, Ramsey B, Griese M; VX17-445-105 Study Group. Daines CL, et al. Among authors: costa s. Eur Respir J. 2023 Dec 7;62(6):2202029. doi: 10.1183/13993003.02029-2022. Print 2023 Dec. Eur Respir J. 2023. PMID: 37945033 Free PMC article. Clinical Trial.
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial.
Griese M, Costa S, Linnemann RW, Mall MA, McKone EF, Polineni D, Quon BS, Ringshausen FC, Taylor-Cousar JL, Withers NJ, Moskowitz SM, Daines CL. Griese M, et al. Among authors: costa s. Am J Respir Crit Care Med. 2021 Feb 1;203(3):381-385. doi: 10.1164/rccm.202008-3176LE. Am J Respir Crit Care Med. 2021. PMID: 32969708 Free PMC article. Clinical Trial. No abstract available.
Correction: Consensus‑driven protocol for transanal irrigation in patients with low anterior resection syndrome and functional constipation.
Martellucci J, Falletto E, Ascanelli S, Bondurri A, Borin S, Bottini C, Caproli E, Carrera M, Cestaro G, Chimisso L, Clarizia G, Clementi I, Cornaglia S, Costa S, Gallo G, Guerci C, Bellini M, Lambiase C, Lauretta A, Luffarelli P, Neri MC, Piccolo D, Rosati E, Rossitti P, Spolini A, Torchia G, Valloncini E, Zattoni D, Zucchi E, Biotti P, Cambareri A, Coniglio G, Coppola A, Nepote Fus K, Graziani S, Grilli M, Grego A, Guerra E, Livio E, Manganini L, Mazzeo P, D'Alba L, Minonne A, Mirafiori M, Negri G, Palazzolo V, Di Pasquale C, Tantolo V. Martellucci J, et al. Among authors: costa s. Tech Coloproctol. 2025 Jan 3;29(1):40. doi: 10.1007/s10151-024-03105-z. Tech Coloproctol. 2025. PMID: 39753936 No abstract available.
Type 2 inflammation: a Portuguese consensus using Web-Delphi and decision conferencing (INFLAT2-PT).
Costa S, Aguiar JP, Oliveira MD, Gonçalves J, Ribeiro JC, Taborda-Barata L, Farinha H, Escada P, Fernandes S, Soares-de-Almeida L, Paiva-Lopes MJ, Chaves Loureiro C, Lourinho I, Fonseca JA, Drummond M, Marinho RT, Bana E Costa J, Vaz Carneiro A, Bana E Costa CA. Costa S, et al. Expert Rev Clin Immunol. 2025 Jan 7:1-15. doi: 10.1080/1744666X.2024.2448990. Online ahead of print. Expert Rev Clin Immunol. 2025. PMID: 39748205
3,669 results